MHT Flashcards
Symptoms (5 domains)
1) VASOMOTOR: flushes
2) GUT: frequency/stress incont/dyspareunia
3) MOOD: depression/anxiety , irritable,s wings
4) SOMATIC: restless, headches, bloating
5) OTHER: insomnia, lower concentration, fatigue, word finding difficulties
USE MRQ QUESTIONAIRE
history
Sx
Periods
?uterus
Age BMI PHx / comorbidities - OP/cvasc RF/VTE, BMD risks (weight/malabs/steroid) FHx - OP/cvasc/cancer/vte Occupation
mammogram
fobt
cst
metabolic check up (5 yearly lipids if low risk; 3 yearly AUSDRISK if low risk)
contraceptive needs: < 50; mirena also a good option or very low dose cocp if non smoker/low cvasc
absolute contraindication
undiagnosed PV bleeding
breast cancer
endometrial cancer
ovarian cancer
relative contraindication
established CVD
VTE
liver disease
migraine w aura
pro
symptom control/improved QOL
bone impacts - benefit to fracture risk
cvasc - can benefit
con
WHI initially thought to be danger, now redone
breast cancer only really > 5 year or use or > 60 yo when starting
- even then 3: 1000 to 4: 1000
- some progesterones are safer than others : micronized prog /dyprogesterones > MDPA.
VTE 1: 10 000 –> 3: 10 000, pregnancy/COCP much higher
PO: cholecystitis
SFX
weight gain
breast tenderness
spotting, particularly within 1 year and cyclical
non pharma
breathable clothes cooler environment/fans/AC avoid etOH/spicy foods healthy diet/regular exercise CBT/stress management
continuous
- > 1 year from period
- or 3 months of cyclical
PO: femosten continous (uses dydrogesterone)
Transdermal: estalis continuous (better for HTN/DM/hyperchol as less VTE/CVA risk)
can just do oestrogen if no uterus; or if mirena in.
cyclical
- within 1 year of period
PO: femosten 1/10 (uses dydrogesterone)
Transdermal: estalis sequ (better for HTN/DM/hyperchol as less VTE/CVA risk)
PV: ovestin topically or pessary.
non MHT based Rx. (4)
- venlefaxine 75mg SR
- tibolone - only > 1 year post menopausal, helps w low libido
- gabapentin - helps w sleep issue, 100 mg nocte
- clonidine 25mg BD
CAM
black kohosh has most research, but benefit evidence very limited/not enough safety data. liver SFX
compounding pharmaceuticals - no evidence. and no evidence the prog is safe for uterus.
F/U
3 months MRQ prior dose adjust/SFX adjust/change up. gradually reduce as time goes on aim < 5 years.